Filing Details
- Accession Number:
- 0001104659-14-047526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-20 17:37:57
- Reporting Period:
- 2014-06-19
- Filing Date:
- 2014-06-20
- Accepted Time:
- 2014-06-20 17:37:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449535 | M Christopher Hall | 7000 Shoreline Court, Suite 250 South San Francisco CA 94080 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-19 | 3,000 | $0.80 | 3,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-19 | 3,000 | $14.99 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-06-19 | 3,000 | $0.00 | 3,000 | $0.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 109,500 | 2020-03-29 | No | 4 | M | Direct |
Footnotes
- This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 19, 2014.
- Represents weighted average sale price. Actual sale prices ranged from $14.80 to $15.34.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- The option award is immediately exercisable, subject to the Issuer's right of repurchase. The option award vested as to 1/4 of the total number of shares subject to the option one year after March 15, 2010, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the option for each month of continuous service thereafter.
Billionaire Hedge Funds
